Finance

Beta
Lists
ELDN:NASDAQ
Eledon Pharmaceuticals Inc
$3.96
+0.25%
(+0.0100) 1D
$4.19
+5.69% (+0.23)
Pre-market
Closed: Jun 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELDN...
Open
$4.06
High
$4.30
Low
$3.85
Mkt. cap
306.44M
Avg. vol.
1.27M
Volume
160.00
52-wk high
$4.60
52-wk low
$1.36
EPS
-$0.83
Beta
0.94
Shares outstanding
77.19M
No. of employees
33
Open
$4.06
High
$4.30
Low
$3.85
Mkt. cap
306.44M
Avg. vol.
1.27M
Volume
160.00
52-wk high
$4.60
52-wk low
$1.36
EPS
-$0.83
Beta
0.94
Shares outstanding
77.19M
No. of employees
33
News stories
From sources across the web
About Eledon Pharmaceuticals Inc
CEO-
Employees33
Founded2004
HeadquartersIrvine, California, United States
SectorBiotechnology
Websiteeledon.com
Analyst Ratings
Based on 3 analysts giving stock ratings to ELDN in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ELDN in the last 3 months.
Highest
Current $3.96
$10.00 (+152.53%)
Average
$8.67 (+118.94%)
Lowest
$8.00 (+102.02%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
$10.00
+152.5%
06/23/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
$8.00
+102%
06/22/2026
Rami Katkhuda
LifeSci Capital
Buy
Reiterated
$8.00
+102%
06/22/2026
Vamil Divan
Guggenheim
Buy
Maintained
$8.00
+102%
03/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.28M
14.97M
17.49M
17.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.46M
4.10M
3.99M
3.98M
Operating expense
24.73M
19.07M
21.48M
21.18M
Total operating expenses
24.73M
19.07M
21.48M
21.18M
Operating income
-24.73M
-19.07M
-21.48M
-21.18M
Other non operating income
13.52M
1.61M
11.07M
-17.84M
EBT including unusual items
-11.22M
-17.46M
-10.41M
-39.02M
EBT excluding unusual items
-11.22M
-17.46M
-10.41M
-39.02M
Income tax expense
-
-
35.00K
-
Effective tax rate
-
-
-0.34%
-
Other operating expenses
-
-
-
-
Net income
-11.22M
-17.46M
-10.45M
-39.02M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.21
-0.10
-0.33
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer